Abdelhakim Allali

Showing 1-6 of 6 articles

Coronary interventions

Super High-Pressure Balloon versus Scoring Balloon to Prepare Severely Calcified Coronary Lesions: The ISAR-CALC Randomized Trial

Rheude T, Rai H, Richardt G, Allali A, Abdel-Wahab M, Sulimov D, Mashayekhi K, Ayoub M, Cuculi F, Bossard M, Kufner S, Xhepa E, Kastrati A, Fusaro M, Joner M, Byrne R, Cassese S

December 4, 2020 | 10.4244/EIJ-D-20-01000

Outcomes of rotational atherectomy versus modified balloon angioplasty in severely calcified coronary lesions based on target lesion location: a post hoc analysis of the PREPARE-CALC randomised trial

Rheude T, Toelg R, Byrne R, Allali A, Wiebe J, Sulimov D, Voll F, Cassese S, Richardt G, Kastrati A, Abdel-Wahab M

July 17, 2020 | 10.4244/EIJ-D-19-00488

Interventions for valvular disease

Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL multicentre, single-arm, pilot study

Schäfer U, Butter C, Landt M, Frerker C, Treede H, Schirmer J, Koban C, Allali A, Schmidt T, Charitos E, Conradi L

October 4, 2019 | 10.4244/EIJ-D-19-00331

Interventions for valvular disease

Long-term durability and haemodynamic performance of a self-expanding transcatheter heart valve beyond five years after implantation: a prospective observational study applying the standardised definitions of structural deterioration and valve failure

Holy E, Kebernik J, Abdelghani M, Stampfli SF, Hellermann J, Allali A, El-Mawardy M, Sachse S, Lüscher T, Tanner F, Richardt G, Abdel-Wahab M

July 20, 2018 | 10.4244/EIJ-D-18-00041

Interventions for valvular disease

Impact of femoral artery puncture using digital subtraction angiography and road mapping on vascular and bleeding complications after transfemoral transcatheter aortic valve implantation

El-Mawardy M, Schwarz B, Landt M, Sulimov D, Kebernik J, Allali A, Becker B, Toelg R, Richardt G, Abdel-Wahab M

January 20, 2017 | 10.4244/EIJ-D-15-00412

Interventions for valvular disease

Redo TAVI: initial experience at two German centres

Schmidt T, Frerker C, Alessandrini H, Schlüter M, Kreidel F, Schäfer U, Thielsen T, Kuck K, Jose J, Holy E, El-Mawardy M, Allali A, Richardt G, Abdel-Wahab M

September 18, 2016 | 10.4244/EIJV12I7A144

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

The Year in Review

M. Lunardi et al.

January 22, 2021

Valvular disease